Understanding the Link Between PCOS and Depression – Explore Our Latest Insights Now!
Read Now
Our Fertility Partner
Dr Mazen Dayeh

Make Your Dream of Parenthood a Reality

Best IVF Doctor in Dubai
80% success rate for fertility in females diagnosed with PCOS
20+ Years of experience
Connect Now

20+ Years Expertise

Dr Mazen Dayeh – The IVF Doctor is a renowned IVF and Fertility Specialist based in Dubai UAE with over 20 plus years of being a qualified Gynaecologist.

80% Fertility Success

Dr Mazen Dayeh specialises in supporting females diagnosed with PCOS in supporting them with an 80% success rate of successful fertility.

Success Secured

PCOS Relief are delighted to have Dr Dayeh, as our Fertility Partner, providing the confidence, security and success of a successful fertility.
Facing Challenges with Fertility because of PCOS?

Our dedicated team is here to support you on this journey.

Connect Now
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Avatar photoAvatar photoAvatar photo

Seeking Support? Start Your PCOS Journey Now

Explore a wealth of resources and a supportive community dedicated to empowering you on your PCOS journey. Join us today.
Contact Now
Official update · May 2026

A landmark update
for 170 million
women worldwide

Previously PCOS Polycystic Ovary Syndrome
→
Now officially PMOS Polyendocrine Metabolic Ovarian Syndrome

Published in The Lancet, May 2026 · Endorsed by the Endocrine Society · 56 global organisations

What was PCOS?

A hormonal condition named after the appearance of follicles on the ovaries — a term widely recognised as inaccurate, leading to delayed diagnoses and misunderstood care for millions.

What is PMOS?

A complex, long-term condition involving multiple hormone imbalances, metabolic effects like insulin resistance, and impacts on reproductive, mental, and cardiovascular health — far beyond just the ovaries.

After a decade-long global study with 22,000+ patients and clinicians, the new name was published in The Lancet to reduce diagnostic delays affecting up to 70% of women living with this condition.